Milich; David R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Milich; David R..The latest application filed is for "hybrid hepadnavirus cores carrying multiple malaria parasite epitopes".

Company Profile

2.12.12

Milich; David R. - Escondido CA
Milich; David R. - Ramona CA
Milich; David R. - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Hybrid hepadnavirus cores carrying multiple malaria parasite epitopes Grant 11,235,045 - Milich , et al. February 1, 2	2022-02-01
Hybrid Hepadnavirus Cores Carrying Multiple Malaria Parasite Epitopes App 20190209672 - MILICH; David R. ; et al.	2019-07-11
Rodent hepadnavirus cores with reduced carrier-specific antigenicity Grant 10,300,124 - Milich , et al.	2019-05-28
Palivizumab Epitope-based Virus-like Particles App 20160039883 - MILICH; David R. ; et al.	2016-02-11
Rodent Hepadnavirus Cores With Reduced Carrier-specific Antigenicity App 20160022801 - MILICH; David R. ; et al.	2016-01-28
Hepatitis Virus Core Proteins As Vaccine Platforms And Methods Of Use Thereof App 20110206724 - MILICH; David R. ; et al.	2011-08-25
Hepatitis virus core proteins as vaccine platforms and methods of use thereof Grant 7,883,843 - Milich , et al. February 8, 2	2011-02-08
Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof Grant 7,811,576 - Milich , et al. October 12, 2	2010-10-12
Compositions And Methods For Treating Intracellular Diseases App 20100203074 - Sallberg; Matti ; et al.	2010-08-12
Compositions and methods for treating intracellular diseases Grant 7,763,589 - Sallberg , et al. July 27, 2	2010-07-27
Rodent hepatitis B virus core proteins as vaccine platforms and methods of thereof App 20080220009 - Milich; David R. ; et al.	2008-09-11
Hepadna virus core proteins as vaccine platforms and methods of use thereof App 20080138892 - Milich; David R. ; et al.	2008-06-12
Hepatitis Virus Core Proteins as Vaccine Platforms and Methods of Use Thereof App 20080131452 - Milich; David R. ; et al.	2008-06-05
Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof Grant 7,320,795 - Milich , et al. January 22, 2	2008-01-22
Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof Grant 7,144,712 - Milich , et al. December 5, 2	2006-12-05
Malaria immunogen and vaccine App 20050208068 - Milich, David R. ; et al.	2005-09-22
Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof App 20050025781 - Milich, David R. ; et al.	2005-02-03
Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof App 20050025782 - Milich, David R. ; et al.	2005-02-03
Compositions And Methods For Treating Intracellular Diseases App 20020165172 - SALLBERG, MATTI ; et al.	2002-11-07
T cell epitopes of the hepatitis B virus nucleocapsid protein Grant 5,143,726 - Thornton , et al. * September 1, 1	1992-09-01
T cell epitopes of the hepatitis B virus nucleocapsid protein Grant 4,882,145 - Thornton , et al. * November 21, 1	1989-11-21
T cell epitopes of the hepatitis B virus nucleocapsid protein Grant 4,818,527 - Thornton , et al. April 4, 1	1989-04-04
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants Grant 4,599,230 - Milich , et al. July 8, 1	1986-07-08
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants Grant 4,599,231 - Milich , et al. July 8, 1	1986-07-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.